
1. Technology overview
Medisafe Project Ltd. lists a Haifa, Israel address in its privacy policy, with offices in Needham, Massachusetts and London; no founding year is stated. The company runs a patient engagement platform that helps pharmaceutical brands extend support into patients' daily lives to improve activation, adherence and persistence.
The platform combines a patient medication management app, behavior-driven digital engagement, provider tools for support between visits and outcome measurement. The site cites 25 or more pharma partners, 13 million patients supported and use in more than 150 countries, across therapeutic areas such as cardiovascular, immunology, mental health, metabolic and GLP-1, neurology and oncology.
2. Highlighted features & specifications
- Patient app: medication management and reminders for patients.
- Behavior-driven engagement: personalized digital support to improve activation and adherence.
- Provider tools: between-visit support for care teams.
- Outcome measurement: tracks persistence and adherence results.
- Therapeutic area programs: cardiovascular, immunology, mental health, metabolic, neurology and oncology.
- AI messaging: research on AI-generated adherence messages published in October 2026.
3. Potential application
A pharmaceutical company in Vietnam could launch a patient support program for diabetes or hypertension drugs through the app. Hospital pharmacies could use reminders for chronic patients after discharge. Insurers could study adherence programs to reduce claims events.
4. Benefits
The site reports up to 50x ROI, 15% higher therapy persistence at 24 months and a 17% increase in medication adherence (company figures). Behavior-driven messaging supports patients between visits. Outcome measurement lets pharma partners track persistence. IQVIA validation and NIH-published research are cited.
5. Market trends & opportunities
Pharmaceutical companies are investing in digital companions to raise persistence for chronic and GLP-1 therapies. In Southeast Asia, chronic disease burdens and growing smartphone use create demand for adherence programs, which pharma and pharmacy partners could run through a multilingual app.
6. Other information
Legal entity Medisafe Project Ltd., Haifa, Israel, with US and UK offices (privacy policy). The site cites 25+ pharma partners and use in 150+ countries. Founding year, certifications and pricing are not stated on the site.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
EDTECH: LEVERAGING AI-POWERED TECHNOLOGIES TO TRANSFORM THE LEARNING EXPERIENCE








































